Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in Europe
Open Access
- 1 June 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (11) , 1577-1584
Abstract
Background. In 1999–2000, reports of fatalities after vaccination with 17D-derived yellow fever vaccine (YEL) focused mainly on cases of YEL-associatKeywords
This publication has 41 references indexed in Scilit:
- 17D yellow fever vaccines: New insightsVaccine, 2007
- High stability of yellow fever 17D-204 vaccine: A 12-year restrospective analysis of large-scale productionVaccine, 2007
- Yellow Fever: Epidemiology and PreventionClinical Infectious Diseases, 2007
- Pathogenesis and Pathophysiology of Yellow Fever2003
- Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISATropical Medicine & International Health, 1999
- Anaphylaxis from yellow fever vaccineJournal of Allergy and Clinical Immunology, 1999
- Stability of 17D Yellow Fever Virus Vaccine Using Different StabilizersBiologicals, 1998
- Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infectionJournal of Medical Virology, 1998
- Isolation of Plaque Variants Differing in Virulence from the 17D Strain of Yellow Fever VirusJournal of General Virology, 1981
- Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child1966